Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Greenwich LifeSciences, Inc. - Common stock (NQ:GLSI)

8.950 +0.110 (+1.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Greenwich LifeSciences, Inc. - Common stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Renalytix AI (NASDAQ:RNLX) shares rose 21.41% to $30.62 during Thursday's regular session. Renalytix AI's stock is trading at a volume of 1.0 million... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?
The top-performing IPO of 2020 is a high-risk, high-reward opportunity, with one drug in its pipeline and one disease in its sights. Is it worth investing in now? 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
Insider Buys Greenwich LifeSciences Shares
Greenwich LifeSciences Inc (NASDAQ:GLSI) was trading 4.4% higher from the previous closing price. CEO Patel Snehal filed a Form 4 with the SEC on Wednesday, April 14. The... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Akumin (NASDAQ:AKU) shares increased by 13.54% to $3.52 during Wednesday's pre-market session. The market value of their outstanding shares is at $247.0... 
Via Benzinga
Greenwich LifeSciences Announces Update of GP2 Phase III Clinical Trial Design at the 2021 AACR Annual Meeting
From Greenwich LifeSciences, Inc.
Via Business Wire
55 Biggest Movers From Yesterday
Gainers Celcuity Inc. (NASDAQ: CELC) jumped 29.4% to settle at $27.94. Celcuity shares climbed 51% on Friday after the company announced a worldwide licensing agreement with... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Intec Pharma (NASDAQ:NTEC) shares increased by 7.67% to $4.35 during Monday's after-market session. Intec Pharma's trading volume hit 412 shares by close,... 
Via Benzinga
Why Greenwich LifeSciences Stock Tanked Today
The drop came despite the clinical-stage biotech announcing good news over the weekend. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers 180 Life Sciences (NASDAQ:ATNF) shares increased by 27.31% to $12.4 during Monday's regular session. Trading volume for 180 Life Sciences's stock is 29.3... 
Via Benzinga
42 Stocks Moving In Monday's Mid-Day Session
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 44.8% to $8.05 after the company's 13D filing showed that Modell's Sporting Goods had reported a stake... 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; Microsoft To Acquire Nuance
Following the market opening Monday, the Dow traded down 0.27% to 33,708.58 while the NASDAQ fell 0.54% to 13,825.03. The S&P also fell, dropping 0.20% to 4,120.48. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Auris Medical Holding (NASDAQ:EARS) stock increased by 21.8% to $5.25 during Monday's pre-market session. The company's market cap stands at $67.5 million... 
Via Benzinga
28 Stocks Moving in Monday's Pre-Market Session
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) rose 73.6% to $9.65 in pre-market trading. Modell's Sporting Goods reported a stake of 18.4% in a 13D filing on Friday.... 
Via Benzinga
REPEAT/Greenwich LifeSciences Presents Phase IIb Poster, Published April 10th at 2021 AACR Annual Meeting, Showing GP2 Immune Response Peaked at 6 Months, Resulting in 100% Disease Free Survival from Recurring Breast Cancer
From Greenwich LifeSciences, Inc.
Via Business Wire
51 Biggest Movers From Friday
Gainers Celcuity Inc. (NASDAQ: CELC) shares climbed 50.9% to close at $21.60 on Friday after the company announced a worldwide licensing agreement with Pfizer to develop and... 
Via Benzinga
Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recurring Breast Cancer
From Greenwich LifeSciences, Inc.
Via Business Wire
38 Stocks Moving In Friday's Mid-Day Session
Gainers Celcuity Inc. (NASDAQ: CELC) shares jumped 64.5% to $23.54 after the company announced a worldwide licensing agreement with Pfizer to develop and commercialize... 
Via Benzinga
Why Greenwich LifeSciences Stock Is Rising Today
The company reported positive data for its cancer immunotherapy candidate GP2. 
Via The Motley Fool
What's Going On With GLSI Stock And PSMT Stock Today?
Greenwich Lifesciences Inc (NASDAQ: GLSI) shares are trading higher by more than 15% after the company reported a robust immune response from its Phase 2b data supporting the GP2... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 32.67% to $67.0 during Friday's pre-market session. The company's market cap stands at $860.7... 
Via Benzinga
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8) Aclaris Therapeutics, Inc... 
Via Benzinga
30 Stocks Moving in Friday's Pre-Market Session
Gainers Celcuity Inc. (NASDAQ: CELC) rose 32.3% to $19.00 in pre-market trading after the company reported a worldwide licensing agreement with Pfizer to develop and... 
Via Benzinga
Greenwich LifeSciences' Stock Is Trading Higher After Breast Cancer Immunotherapy Shows 0% Recurrences Over 5 Years Follow-up
Greenwich LifeSciences Inc (NASDAQ: GLSI) has announced the abstract results of the final 5-year immune response data of the Phase 2b trial at the 2021 AACR... 
Via Benzinga
Greenwich LifeSciences Reports Robust Immune Response Phase IIb Data Supporting GP2 Clinical Outcome of 0% Metastatic Breast Cancer Recurrences Over 5 Years of Follow-up
From Greenwich LifeSciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers 180 Life Sciences (NASDAQ:ATNF) stock increased by 21.18% to $9.61 during Thursday's regular session. Trading volume for this security as of 12:32 EST is 9.2... 
Via Benzinga
28 Stocks Moving In Wednesday's Mid-Day Session
Gainers UTime Limited (NASDAQ: UTME) jumped 97.4% to $76.99. UTime shares jumped 875% on Tuesday after the company priced its IPO at $4 per share. XL Fleet Corp. (NASDAQ: XL)... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
20 Stocks Moving in Wednesday's Pre-Market Session
Gainers UTime Limited (NASDAQ: UTME) rose 39.7% to $54.50 in pre-market trading. UTime shares jumped 875% on Tuesday after the company priced its IPO at $4 per share. SOS... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
51 Biggest Movers From Yesterday
Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the company priced its IPO at $4 per share. Romeo Power, Inc. (NYSE: RMO) climbed 59.6... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 33.37% to $9.87 during Tuesday's regular session. As of 12:32 EST, this security is trading at a volume... 
Via Benzinga
33 Stocks Moving In Tuesday's Mid-Day Session
Gainers Scienjoy Holding Corporation (NASDAQ: SJ) shares jumped 67.4% to $16.04 after the company announced a strategic alliance with Snipp to launch a new loyalty and rewards... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.